Gå direkt till huvudinnehållet

Erektil dysfunktion

Senast uppdaterad: Senast reviderad:
Sakkunnig:


Definition:
Oförmåga att få erektion.
Förekomst:
Prevalensen ökar med åldern och är cirka 20–25 % bland män >65 år 
Symtom:
Symtomen innebär oförmåga till resning av penis, det vill säga uteslutning har skett av sviktande lust, oförmåga till orgasm eller ejakulationssvårigheter.
Kliniska fynd:
Oftast inga lokala fynd, men det kan finnas tecken på generell ateroskleros.
Diagnostik:
Inga specifika undersökningar.
Behandling:
Behandling riktas mot att elimininera underliggande orsaker, eventuellt kan erektionsstimulerande medel, psykoterapi och/eller stötvågsbehandling ges. 
  1. Kim ED. Erectile dysfunction. Medscape, last updated Oct 12, 2015.
  2. Heidelbaugh JJ. Management of erectile dysfunction. Am Fam Physician 2010; 81: 305-12. American Family Physician  
  3. Tomlinson J, Wright D. Impact of erectile dysfunction and its subsequent treatment with sildenafil: qualitative study. BMJ 2004; 328: 1037. PubMed  
  4. Feldman HA, Goldstein I, Hatzichristou DG et al. Impotence and its medical and psychosocial correlates: Results of the Massachusetts male aging study. J Urol 1994; 151: 54-61. PubMed  
  5. Svendsen K-OB, Schultz A. Seksuell dysfunksjon hos menn. Tidsskr Nor Legeforen 2008; 128: 448-52. Tidsskrift for Den norske legeforening  
  6. Janusinfo, Stockholms läns landsting, publicerat 2016-04-08 www.janusinfo.se  
  7. De Nunzio C, Roehrborn CG, Andersson KE, McVary KT. Erectile Dysfunction and Lower Urinary Tract Symptoms. Eur Urol Focus. 2017 Oct;3(4-5):352-363. doi: 10.1016/j.euf.2017.11.004. Epub 2017 Nov 27. PMID: 29191671. PubMed  
  8. Cai X, Tian Y et al. The role of statins in erectile dysfunction: a systematic review and meta-analysis. Asian J Androl 2014; 16 (3): 461–466. doi: 10.4103/1008-682X.123678Cai X, Tian Y et al. The role of statins in erectile dysfunction: a systematic review and meta-analysis. Asian J Androl 2014; 16(3): 461-6. DOI  
  9. Cui Y1, Zong H et al. The effect of statins on erectile dysfunction: a systematic review and meta-analysis. J Sex Med 2014; 11(6): 1367-75. PubMed  
  10. Kostis JB, Dobrzynski JM. The effect of statins on erectile dysfunction: a meta-analysis of randomized trials. J Sex Med 2014; 11 (7): 1626–1635. PMID: 24684744 PubMed  
  11. Davis R, Reveles KR et al. Statins and male sexual health: a retrospective cohort analysis. J Sex Med 2015; 12(1): 158-67. PubMed  
  12. Johannes CB, Araujo AB, Fleldman RA et al. Incidence of erectile dysfunction in men 40 to 69 years old: longitudinal results from the Massachusetts male aging study. J Urol 2000; 163: 460-3. PubMed  
  13. Ralph D, McNicholas T. UK management guidelines for erectile dysfunction. BMJ 2000; 321: 499-503. British Medical Journal  
  14. Rekommendationer för behandling av erektil dysfunktion. Janusinfo. region Stockholm. Hämtad 2020-10-15 janusinfo.se  
  15. Esposito K, Giugliano F, Di Palo C, et al. Effect of Lifestyle Changes on Erectile Dysfunction in Obese Men: A Randomized Controlled Trial. JAMA 2004; 291: 2978-84. PubMed  
  16. Tstertsavadze A, Fink HA, Yazdi F, et al. Oral phosphodiesterase-5 inhibitors and hormonal treatments for erectile dysfunction: A systematic review and meta-analysis. Ann Intern Med 2009; 151: 650-61. Annals of Internal Medicine  
  17. Mittleman MA, Glasser DB, Orazem J, Collin M. Incidence of myocardial infarction and death in 53 clonical trials of Viagra. J Am Coll Cardiol 2000; 35: 302A.
  18. Zusman RM, Morales A, Glasser DB, Osterloh IH. Overall cardiovascular profile of sildenafil citrate. Am J Cardiol 1999; 83: 35C-44C.
  19. FDA, Food And Drug Administration. FDA Announces Revisions to Labels for Cialis, Levitra and Viagra Potential risk of sudden hearing loss with ED drugs to be displayed more prominently
  20. Doggrell S. Do vardenafil and tadalafil have advantages over sildenafil in the treatment of erectile dysfunction? Int J Imp Res 2007; 19: 281-95. PubMed  
  21. Moore RA, Derry S, McQuay HJ. Indirect comparison of interventions using published randomised: systematic review of PDE-5 inhibitors for erectile dysfunction. BMC Urology 2005; 5: 18. PubMed  
  22. Goldstein I, Lue TF, Padma-Nathan H, Rosen RC, Steers WD, Wicker PA. Oral sildenafil in the treatment of erectile dysfunction. N Engl J Med 1998; 338: 1397-404. PubMed  
  23. Tharyan P, Gopalakrishanan G. Erectile dysfunction. Clin Evid. 2006 Jun;(15):1227-51. PMID: 16973050 PubMed  
  24. Nandipati K, Raina R, Agarwal A et al. Erectile dysfunction following radical retropubic prostatectomy: epidemiology, pathophysiology and pharmacological management. Drugs Aging 2006; 23: 101-17. PubMed  
  25. Briganti A, Salonia A, Gallina A et al. Management of erectile dysfunction after radical prostatectomy in 2007. World J Urol 2007; 25: 143-8. PubMed  
  26. Wu Y, Qu X, Wang Y, Xia J, Gu Y, Qian Q, Hong Y. Effect of phosphodiesterase type 5 inhibitors on prostate cancer risk and biochemical recurrence after prostate cancer treatment: A systematic review and meta-analysis. Andrologia 2018. PMID: 30443968 PubMed  
  27. Stridh A, Pontén M, Arver S, et al. Placebo Responses Among Men With Erectile Dysfunction Enrolled in Phosphodiesterase 5 Inhibitor Trials A Systematic Review and Meta-analysis. JAMA Netw Open 2020. doi:10.1001/jamanetworkopen.2020.1423 jamanetwork.com  
  28. Hong B, Ji YH, Hong JH, Nam KY, Ahn TY. A double-blind crossover study evaluating the efficacy of Korean red ginseng in patients with erectile dysfunction: a preliminary report. J Urol 2002; 168: 2070-3. PubMed  
  29. O'Leary M. Erectile dysfunction. Clin Evid 2001; 6: 667-73. PubMed  
  30. Melnik T, Soares B, Nasselo A. Psychosocial interventions for erectile dysfunction. Cochrane Database Syst Rev, issue 3, 2007. The Cochrane Library  
  31. Gruenwald I, Appel B, Kitrey ND, Vardi Y. Shockwave treatment of erectile dysfunction. Ther Adv Urol 2013; 5(2): 95-99. pmid:PMID: 23554844 PubMed  
  32. Montorsi P, Ravagnani PM, Galli S, et al. Association between erectile dysfunction and coronary artery disease. Role of coronary clinical presentation and extent of coronary vessels involvement: the COBRA trial. Eur Heart J 2006; 27: 2632-9. European Heart Journal  
  33. Blumentals WA, Gomez-Caminero A, Joo S, Vannappagari V. Is erectile dysfunction predictive of peripheral vascular disease? Aging Male 2003; 6: 217-21. PubMed  
  • Anna Nager, med dr och specialist i allmänmedicin, Karolinska institutet

Tidigare sakkunniga

  • Jan-Erik Damber, professor och överläkare, Enheten för urologi, Sahlgrenska universitetssjukhuset, Göteborg